SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology CD40 products
includes other brands or spellings
|
| block | | Santa Cruz Biotechnology polyclonal anti-hCD40 antibody (LOB-11) was used in activating expriments to study the function of an atypical TNFR-associated factor-binding motif of BAFFR to mediate induction of the noncanonical NF-kappaB signaling pathway. |
| chip | | Santa Cruz Biotechnology polyclonal antibody against p50 was used in CHIP assay to investigate the IL-8 and IkappaBalpha gene regulatory regions in A549 human lung carcinoma cells. |
| chip | | Santa Cruz Biotechnology antibody to p50 was used in chromatin immunoprecipitation to study the coactivators and corepressors of NF-kappa B in I kappa B alpha gene promoter. |
| emsa | | Santa Cruz Biotechnology anti-p50 antibody was used in EMSA to study the effect of mutated IκB kinase and IκBα on HAS1 activation. |
| ip | | Santa Cruz Biotechnology polyclonal goat anti-CD40 antibody was used in immunoprecipitation to study the endothelial cell survival and in vitro angiogenesis mediating by CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway. |
BD BIOSCIENCES search BD Biosciences CD40 products
includes other brands or spellings
|
| emsa | | Pharmingen mouse anti-CD40 antibody was used in EMSA to study the function of tumor suppressor CYLD in the regulation of JNK signaling. |
| emsa | | BD PharMingen anti-CD40 antibody was used in EMSA to study the regulation of human 3' Igh hs4 enhancer activity in B cells by synergistic interaction between Oct-2 and NF-kappaB. |
| flow | | BD Biosciences fluorescein isothiocyanate-conjugated anti-hCD40 antibody was used in flow cytometry to study the function of an atypical TNFR-associated factor-binding motif of BAFFR to mediate induction of the noncanonical NF-kappaB signaling pathway. |
| flow | | BD PharMingen monoclonal anti-CD40 antibody was used in flow cytometry to study the effect of serine protease plasmin on expression of MCP-1 and CD40 in human primary monocytes. |
| flow | | BD Pharmingen monoclonal PE-CAM antibody was used in flow cytometry to study surface downregulation of MHC class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with KSHV. |
| flow | | BD Pharmingen murine monoclonal PE anti-CD40 antibody (5C3) was used in human myeloma cell lines and in flow cytometry to study the role for polyclonal rabbit antithymocyte globulin in apoptosis and complement-mediated lysis of myeloma cells. |
| wb | | BD PharMingen anti-CD40 antibody was used in western blot to study the activation of NF-kappaB. |
ATCC search ATCC CD40 products
includes other brands or spellings
|
| block | | American Type Culture Collection anti-hCD40 monoclonal antibody (clone G28–5) was used in activating expriments to study the function of an atypical TNFR-associated factor-binding motif of BAFFR to mediate induction of the noncanonical NF-kappaB signaling pathway. |
| block | | ATCC anti-CD40 monoclonal antibody was used in blocking or activating experiments to stimulate human B lymphoma cell line ramos 2G6. |
| flow | | American Type Culture Collection monoclonal antibody against CD40 (clone G28.5) was used in flow cytometry to study the important functional role of ICOS-ligand which is expressed on human endothelial cells to costimulate Th1 and Th2 cytokine secretion by memory CD4+ T cells. |
| ip | | American Type Culture Collection anti-hCD40 hybridoma antibody (clone G28-5, mouse IgG1) was used in immunoprecipitation and activating experiments to study the interaction of LMP1 protein from the Epstein-Barr virus with TRAF3 in B lymphocytes. |
BECKMAN COULTER search Beckman Coulter CD40 products
includes other brands or spellings
|
| ih | | Immunotech CD40 mAb was used in immunohistochemistry to investigate the dysregulated expression of IL-18 and/or IL-18R in chronic B-cell lymphoproliferative disorders deriving from naive, germinal center, and memory B lymphocytes. |
| ih | | Immunotech mouse CD40 (clone MAB 89) antibody was used in immunohistochemistry to study CD40 and CD40L expression after restorative proctocolectomy for ulcerative colitis. |
| ih | | Dako Cytomation monoclonal Epstein-Barr virus-associated latent membrane protein-1 (LMP-1) antibody (CS1–4) was used in immunohistochemistry to study OCT-1, OCT-2, and BOB-1/OCA-B expression in normal lymphoid tissue and in T-cell neoplasms. |
LEICA MICROSYSTEMS search Leica Microsystems CD40 products
includes other brands or spellings
|
| ih | | Novocastra CD40 antibody was tested in immunohistochemistry by HPA (CAB002495) . |
| ih | | NovoCastra Laboratories anti-CD40 antibody 11E-9 was used in the paraffin sections from human aggressive lymphomas and in immunohistochemistry to study the effect of CD23 and CD40 on identifying prognostically favorable subgroups of diffuse large B-cell lymphoma. |
NOVOCASTRA
|
| ih | | Novocastra CD40 antibody was tested in immunohistochemistry by HPA (CAB002495) . |
Articles Reviewed |
| 1. Saman Khayyamian et al. ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells. 2002 |
| 2. Takechiyo Yamada et al. CD45 controls interleukin-4-mediated IgE class switch recombination in human B cells through its function as a Janus kinase phosphatase. 2002 |
| 3. Kaoru Saijo et al. Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha. 2002 |
| 4. Ladislav Burysek et al. The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)/STAT signaling pathways. 2002 |
| 5. Johan Linderoth et al. Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study. 2003 |
| 6. Teresa Marafioti et al. Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. 2003 |
| 7. Maria Chiara Deregibus et al. CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis. 2003 |
| 8. Costin Tomescu et al. Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus. 2003 |
| 9. Manuel A Sepulveda et al. NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells. 2004 |
| 10. Irma Airoldi et al. Heterogeneous expression of interleukin-18 and its receptor in B-cell lymphoproliferative disorders deriving from naive, germinal center, and memory B lymphocytes. 2004 |
| 11. William Reiley et al. Negative regulation of JNK signaling by the tumor suppressor CYLD. 2004 |
| 12. Matthew D Morrison et al. An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway. 2005 |
| 13. Zhanguo Gao et al. Coactivators and corepressors of NF-kappaB in IkappaB alpha gene promoter. 2005 |
| 14. Hans F Luecke et al. The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. 2005 |
| 15. ShuangDing Wu et al. LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3. 2005 |
| 16. Lino Polese et al. Persistence of high CD40 and CD40L expression after restorative proctocolectomy for ulcerative colitis. 2005 |
| 17. Karl M Stuhlmeier et al. Adenovirus-mediated gene transfer of mutated IkappaB kinase and IkappaBalpha reveal NF-kappaB-dependent as well as NF-kappaB-independent pathways of HAS1 activation. 2005 |
| 18. Martin S Zand et al. Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin. 2006 |
| 19. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |